$23.730
-1.376 (-5.80%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de NVCT por análisis de gráficos similares
Alphio's NVCT stock price prediction model matches the current Nuvectis Pharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $23.78 (+0.23%). The 1-week path is $23.46 (-1.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Nuvectis Pharma Inc?
Nuvectis Pharma is a good buy right now due to its recent marketing approval for Ciprocopan in China, which is expected to significantly enhance its market position. The stock has shown a remarkable year-to-date change of +178.85% and a one-year change of +271.94%, indicating strong momentum. Additionally, the RSI is at 54.97, suggesting that the stock is neither overbought nor oversold, making it a favorable entry point. However, the main risk is the company's increasing net losses, which reached -$7.0 million in the latest quarter, highlighting ongoing financial challenges.
NVCT cerró en $23.73 el Friday, tras bajar -5.80%
Nuvectis Pharma Inc (NVCT) last closed at $23.73, losing -5.80%. These facts feed the 1-day and 1-week NVCT price prediction above.
Factores de la previsión
Los factores de la previsión de Nuvectis Pharma Inc (NVCT) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de NVCT, ordenadas por similitud.
Análisis de estacionalidad de NVCT
Historically the probability of a positive August return for NVCT is 65.62%. March offers the highest probability of a positive month at 80.95%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de NVCT
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $6.21 | $7.47 | $7.50 | -68.51% |
| Sep 2026 | $7.06 | $7.49 | $8.42 | -68.42% |
| Oct 2026 | $7.82 | $7.98 | $9.18 | -66.35% |
| Nov 2026 | $8.83 | $9.05 | $9.72 | -61.87% |
| Dec 2026 | $8.35 | $9.42 | $10.62 | -60.31% |
En 2026, se proyecta que Nuvectis Pharma Inc (NVCT) oscile entre $6.21 y $10.62.
Previsión mensual de Nuvectis Pharma Inc para 2026
En Aug de 2026, se proyecta que Nuvectis Pharma Inc promedie $7.47, con un mínimo de $6.21 y un máximo de $7.50.
En Sep de 2026, se proyecta que Nuvectis Pharma Inc promedie $7.49, con un mínimo de $7.06 y un máximo de $8.42.
En Oct de 2026, se proyecta que Nuvectis Pharma Inc promedie $7.98, con un mínimo de $7.82 y un máximo de $9.18.
En Nov de 2026, se proyecta que Nuvectis Pharma Inc promedie $9.05, con un mínimo de $8.83 y un máximo de $9.72.
En Dec de 2026, se proyecta que Nuvectis Pharma Inc promedie $9.42, con un mínimo de $8.35 y un máximo de $10.62.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.